Medical Oncology, History and Its Future in Iran Pubmed



Mirzania M¹ ; Ghavamzadeh A² ; Kermani IA³ ; Ashrafi F⁴ ; Allahyari A⁵ ; Rostami N⁶ ; Razavi SM⁷ ; Ramzi M⁸ ; Nemanipour G⁹
Source: Archives of Iranian Medicine Published:2015

Abstract

Systemic therapy is one of the cornerstones of cancer treatment. In 1972, following representations by American Society of Clinical Oncology (ASCO), the American Board of Internal Medicine (ABIM) recognized medical oncology as a new subspecialty of internal medicine. Subspecialty of Hematology and Medical Oncology was emerged in Iran in 1983. In the past, modern medical treatments and education were started in Dar Al-fonun school and then in Tehran University; now six universities in Iran are training in Subspecialty of Hematology and Medical Oncology. There are also ten active hematopoietic stem cell transplantation centers, thirty-one provincial medical schools, as well as medical oncology and hematology care services. Future goals for Hematology and Medical Oncology in Iran include expansion and reinforcement of multidisciplinary teams across the country, early detection and prevention of cancer, providing educational program and conducting cancer researches. To achieve these goals, it is necessary to establish Cancer Hospitals in each province that link together through a network. © 2015, Academy of Medical Sciences of the I.R. Iran. All rights reserved.